Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2144546
Abstract: Abstract The anti-hyperglycemic sodium glucose co-transporter 2 inhibitor Canagliflozin (CFZ) represents a recent antihyperglycemic modality, yet it suffers from low oral bioavailability. The current work aims to formulate CFZ-loaded transdermal nanostructured liquid crystal gel matrix…
read more here.
Keywords:
cfz;
inhibitor;
delivery;
cfz nlcg2 ... See more keywords